US FTC failed to meet its burden, Edwards, JenaValve argue in post-trial brief
MLex Summary: Edwards Lifesciences and JenaValve Technology submitted their post-trial brief and redacted proposed findings of fact and conclusions of law today, arguing that the US Federal Trade Commission failed to...To view the full article, register now.
Already a subscriber? Click here to view full article